Giuseppe Lamorte
Overview
Explore the profile of Giuseppe Lamorte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, et al.
Hum Mol Genet
. 2022 Jul;
31(23):3945-3966.
PMID: 35848942
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying...
2.
Valenti L, Pelusi S, Cherubini A, Bianco C, Ronzoni L, Uceda Renteria S, et al.
Transfusion
. 2021 Oct;
61(12):3381-3389.
PMID: 34647620
Background: A large proportion of SARS-CoV-2-infected individuals does not develop severe symptoms. Serological tests help in evaluating the spread of infection and disease immunization. The aim of this study was...
3.
Valenti L, Griffini S, Lamorte G, Grovetti E, Uceda Renteria S, Malvestiti F, et al.
J Autoimmun
. 2021 May;
120:102646.
PMID: 33940483
No abstract available.
4.
Manunta M, Lamorte G, Ferrari F, Trombetta E, Tirone M, Bianco C, et al.
Sci Rep
. 2021 Mar;
11(1):4904.
PMID: 33649400
SARS-CoV-2 virus infection is responsible for coronavirus disease (COVID-19), which is characterised by a hyperinflammatory response that plays a major role in determining the respiratory and immune-mediated complications of this...
5.
Valenti L, Griffini S, Lamorte G, Grovetti E, Uceda Renteria S, Malvestiti F, et al.
J Autoimmun
. 2021 Jan;
117:102595.
PMID: 33453462
Background: Genetic variation at a multigene cluster at chromosome 3p21.31 and the ABO blood group have been associated with the risk of developing severe COVID-19, but the mechanism remains unclear....
6.
Lombardi A, Trombetta E, Cattaneo A, Castelli V, Palomba E, Tirone M, et al.
Front Immunol
. 2020 Dec;
11:560330.
PMID: 33362757
Background: Severe acute respiratory syndrome coronavirus 2 is a recently discovered pathogen responsible of coronavirus disease 2019 (COVID-19). The immunological changes associated with this infection are largely unknown. Methods: We...
7.
Cugno M, Meroni P, Gualtierotti R, Griffini S, Grovetti E, Torri A, et al.
J Autoimmun
. 2020 Nov;
116:102560.
PMID: 33139116
Background: Animal models and few clinical reports suggest the involvement of the complement system in the onset of severe manifestations of coronavirus disease-2019 (COVID-19). However, complement contribution to endotheliopathy and...
8.
Berzuini A, Bianco C, Paccapelo C, Bertolini F, Gregato G, Cattaneo A, et al.
Blood
. 2020 Jun;
136(6):766-768.
PMID: 32559762
No abstract available.
9.
Bidollari E, Rotundo G, Altieri F, Amicucci M, Wiquel D, Ferrari D, et al.
Stem Cell Res
. 2019 Sep;
40:101551.
PMID: 31493762
Dentato-Rubral-pallidoluysian atrophy (DRPLA) is a rare autosomal, dominant, progressive neurodegenerative disease that causes involuntary movements, mental and emotional problems. DRPLA is caused by a mutation in the ATN1 gene that...
10.
Altieri F, DAnzi A, Martello F, Tardivo S, Spasari I, Ferrari D, et al.
Stem Cell Res
. 2019 Jun;
38:101480.
PMID: 31202121
Joubert syndrome (JS) is an autosomal recessive neurodevelopmental disorder, characterized by congenital cerebellar and brainstem defects, belonging to the group of disorders known as ciliopathies, which are caused by mutations...